Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFC Energy Regulatory News (AFC)

  • There is currently no data for AFC

£4 million Convertible Bond Facility

12 Apr 2019 07:00

RNS Number : 9764V
AFC Energy Plc
12 April 2019
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

 

12 April 2019

 

AFC Energy PLC

 

("AFC Energy" or the "Company")

 

 

£4 million Convertible Bond Facility

 

AFC Energy (AIM: AFC), a leading alkaline fuel cell power company, is pleased to announce that the Company has entered into a financing facility with Thalion Global Group ("Thalion") for up to £4 million (before expenses) (the "Facility"). The Facility allows AFC Energy to draw down up to £4 million through the issuance of unsecured convertible loan notes with a par value of £25,000 each (the "Convertible Loan Notes") to Thalion pursuant to a loan note instrument executed by the Company on 11 April 2019 ("Instrument"). Proceeds from the issuance of Convertible Loan Notes will supplement the Company's cash position, which as of 31 March 2019 was £1.4 million, and will enable AFC Energy to continue its product development and commercialisation strategy.

The Company can draw down up to a maximum amount of £500,000 in any 60 day period. The maturity date of the Convertible Loan Notes is 42 months from the date of the Instrument. The Convertible Loan Notes are issuable at a price of £22,500 (representing a discount of 10% to par value) and are convertible into new ordinary shares of 0.1 pence each in the Company ("Ordinary Shares"), at a price equivalent to the lower of:

· a 25% premium to the volume weighted average price ("VWAP") on the business day before draw down; or

· the lowest VWAP from the three business day period prior to conversion.

The Convertible Loan Notes are convertible at the sole option of the noteholder and become redeemable on the maturity date (subject to any conversion rights being exercised during the term of the Convertible Loan Notes). No application will be made to any listing authority, stock exchange or other market for the Convertible Loan Notes to be listed or otherwise traded.

AFC Energy can redeem the Convertible Loan Notes prior to the maturity date at a price equal to a 5% premium to the par value of the Convertible Loan Notes.

Pursuant to the terms of the Facility, the Company will pay an arrangement fee of £200,000 settled by the issue and allotment of 6,666,667 Ordinary Shares at a price of 3 pence per share.

Application has been made for admission of the 6,666,667 Ordinary Shares issued as payment of the arrangement fee and admission is expected to occur at 8.00 a.m. on 17 April 2019 ("Admission"). Following Admission, the Company will have 398,664,872 Ordinary Shares in issue. Accordingly, following Admission, the total number of voting rights in the Company will be 398,664,872. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Adam Bond, AFC Energy's Chief Executive Officer, said: "AFC Energy has made serious strides forwards over the past twelve months in the commercialisation of its alkaline fuel cell technology and is currently engaging with a number of prospective and strategic partners interested in supporting this effort. The facility entered into today allows the Company to continue to develop these opportunities and capitalise on the value created over the past few years into the foreseeable future in collaboration with our prospective industrial and strategic partners without immediate dilution to existing shareholders".

 

For further information, please contact:

AFC Energy plc

Adam Bond (Chief Executive Officer)

 

 

 

+44 (0) 20 3697 1209

Cantor Fitzgerald Europe Nominated Adviser and Joint Broker

David Foreman

Richard Salmond

 

+44 (0) 20 7894 7000

M C Peat & Co LLP Joint Broker

Charlie Peat

 

+44 (0) 20 7104 2334

 

 

TUVA Partners Public Relations

Julian Tanner

 

+44 (0) 7733 717 995

 

 

 

 

 

 

 

About AFC Energy

 

AFC Energy plc is commercialising a scalable alkaline fuel cell system, to provide clean electricity for on and off grid applications. The technology, pioneered over the past ten years in the UK, is in the process of being deployed in industrial gas plants for grid generation, as an alternative to diesel generators for localised power, in energy storage systems and as the power source for local electricity needs.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CONIBMLTMBBBBAL
Date   Source Headline
12th May 20261:28 pmRNSChange of Name to H-Power plc
30th Apr 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSBlock Listing Return and Total Voting Rights
16th Apr 202612:48 pmRNSResult of AGM
23rd Mar 20267:02 amRNSDirectorate Remuneration and Total Voting Rights
23rd Mar 20267:00 amRNSNotice of 2026 AGM and Change of Name
25th Feb 20267:00 amRNSFinal Audited Results
18th Feb 20267:00 amRNSEA allows AFC to sell hydrogen produced by cracker
10th Feb 20267:00 amRNSJoint Development Agreement with Komatsu Ltd.
9th Feb 20267:00 amRNS-REquipment Demonstration Day For Retail Investors
30th Jan 20267:00 amRNSTotal Voting Rights
21st Jan 20267:00 amRNSOperational Update
20th Jan 20267:00 amRNSNotice of Results
17th Dec 20257:00 amRNSAdmission of Shares and Total Voting Rights
6th Nov 20257:00 amRNSTrading Update for Year Ended 31 October 2025
31st Oct 20257:00 amRNSTotal Voting Rights
27th Oct 20257:00 amRNSBlock Listing Return and Total Voting Rights
21st Oct 20257:00 amRNS-RAFC CTO to Chair new UK Ammonia Alliance group
15th Oct 20257:00 amRNSDirector/PDMR Shareholding
10th Oct 20257:00 amRNSAGM Resolution Vote Update and Change of Broker
15th Sep 20257:00 amRNS-RAppointment of Chief Strategy Officer
14th Aug 202512:29 pmRNSDirector/PDMR Shareholding
14th Aug 202511:50 amRNSDirector/PDMR Shareholding
13th Aug 20255:00 pmRNSDirector/PDMR Shareholding
7th Aug 202510:31 amRNSGeneral Meeting Results and PDMR Shareholding
1st Aug 20257:00 amRNSGrant of Share Options
21st Jul 20255:29 pmRNSRetailBook Offer Result & General Meeting Notice
18th Jul 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
17th Jul 20258:00 amRNSResults of Oversubscribed Placing and Subscription
16th Jul 20256:21 pmRNSInterim Results for half year 2025 – Replacement
16th Jul 20255:36 pmRNSRetailBook Offer
16th Jul 20255:36 pmRNSProposed Placing & Subscription & RetailBook Offer
16th Jul 20255:36 pmRNSInterim Results for the half year to 30 April 2025
4th Jul 20257:00 amRNSNew JV with Industrial Chemicals Group
30th Jun 20257:00 amRNSTotal Voting Rights
13th Jun 20257:00 amRNSOperational Update
4th Jun 202512:06 pmRNSJoint Development Agreement
30th May 20257:00 amRNSTotal Voting Rights
7th May 202511:43 amRNSDirector/PDMR Shareholding
6th May 20253:59 pmRNSDirector/PDMR Shareholding
6th May 20252:05 pmRNSDirector/PDMR Shareholding
2nd May 20252:21 pmRNSDirector/PDMR Shareholding
1st May 20255:40 pmRNSDirector/PDMR Shareholding
25th Apr 20257:00 amRNSBlock Listing Return
23rd Apr 20253:40 pmRNSDirector/PDMR Shareholding
23rd Apr 20251:00 pmRNSAnnual General Meeting Results
28th Mar 20257:00 amRNSNotice of 2025 Annual General Meeting
27th Mar 202510:01 amRNSDirector/PDMR Shareholding
26th Mar 20252:27 pmRNSDirector/PDMR Shareholding
19th Mar 202511:10 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.